Amy K. LeBlanc

Veterinary <scp>Cooperative</scp> Oncology Group—Common Terminology Criteria for Adverse Events (<scp>VCOG‐CTCAE</scp> v2) following investigational therapy in dogs and cats

Amy K. LeBlanc, Matthew J. Atherton, R. Timothy Bentley et al. · Veterinary and Comparative Oncology · 2021 · 322 citations · Full text

Veterinary Medicine, Veterinary Oncology, Veterinary Surgery +15

Masitinib is Safe and Effective for the Treatment of Canine Mast Cell Tumors

K. Hahn, G. Oglivie, Todd Rusk et al. · Journal of Veterinary Internal Medicine · 2008 · 284 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

A Revised Diagnostic Classification of Canine Glioma: Towards Validation of the Canine Glioma Patient as a Naturally Occurring Preclinical Model for Human Glioma

Jennifer W. Koehler, Andrew D. Miller, C. Ryan Miller et al. · Journal of Neuropathology & Experimental Neurology · 2018 · 142 citations · Full text

Medicine, Oncology, Pathology +17

CCNU for the Treatment of Dogs with Histiocytic Sarcoma

Katherine A. Skorupski, Craig A. Clifford, Melissa Paoloni et al. · Journal of Veterinary Internal Medicine · 2007 · 139 citations · Full text

Medicine, Oncology, Veterinary Oncology +11

Launching a Novel Preclinical Infrastructure: Comparative Oncology Trials Consortium Directed Therapeutic Targeting of TNFα to Cancer Vasculature

Melissa Paoloni, Anita Tandle, Christina Mazcko et al. · PLoS ONE · 2009 · 120 citations · Full text

Pharmacy, Cancer Biology, Oncology +16